Abstract:
To study the clinical effect and the security of Foscarnet on the treatment of acute borderling severe hepatitis caused by HBV for preventing severe hepatitis, 19 cases were choosed as treated group, simultaneouly, 21 cases were choosed as control group.All patients in treated group received PFA treatment also used Injection of Hepatocyte Growth-promotting Factors, Diammoninm Glycyrrhizinate Injection, Injection Kalii Magnesii Aspartatis and Injection Thymosini similar to the contrast growp.The change of hepatic function of every patierts was examined before and after treatment.There were significant difference between the two growps in terms of process and TBil, ALT, A/G.PTA and PT et al.by Statistical analysis (P<0.01) .The results show that PFA have benifical effect on preventing acute HBV borderling severe hepatitis from severe hepatitis.